CN Patent

CN108431040B — 利培酮的抗体及其用途

Assigned to Janssen Pharmaceutica NV · Expires 2022-07-26 · 4y expired

What this patent protects

本发明公开了结合至利培酮的抗体或其结合片段，其可用于检测样品中的利培酮，诸如在竞争性免疫测定方法中。所述抗体或其片段可用于利培酮的床旁检测用的侧流测定装置中，包括在单个侧流测定装置中的阿立哌唑、喹硫平、奥氮平和利培酮的多重检测。

USPTO Abstract

本发明公开了结合至利培酮的抗体或其结合片段，其可用于检测样品中的利培酮，诸如在竞争性免疫测定方法中。所述抗体或其片段可用于利培酮的床旁检测用的侧流测定装置中，包括在单个侧流测定装置中的阿立哌唑、喹硫平、奥氮平和利培酮的多重检测。

Drugs covered by this patent

Patent Metadata

Patent number
CN108431040B
Jurisdiction
CN
Classification
—
Expires
2022-07-26
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.